J. Puel

发表

Quantitation of human cytomegalovirus in recipients of solid organ transplants by real‐time quantitative PCR and pp65 antigenemia

C. Mengelle, C. Pasquier, L. Rostaing, 2003, Journal of medical virology.

Differential display fingerprints: new approach to characterize smooth muscle cells and human coronary atherectomy tissues.

J. Puel, F. Heitz, N. Blaes, 2007, Pathologie-biologie.

Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.

G. Salama, C. Pasquier, J. Puel, 1999, Journal of virological methods.

Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.

H. Fleury, P. Massip, J. Puel, 2000 .

Comparative Assessment of Quantitative HIV Viraemia Assays

F. Brun-Vézinet, H. Agut, H. Fleury, 1992, AIDS.

Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.

L. Rostaing, J. Puel, J. Izopet, 1998, Transplantation.

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype.

M. Alvarez, P. Massip, C. Pasquier, 2002, The Journal of infectious diseases.

Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens

B. Masquelier, H. Fleury, J. Puel, 1996, Journal of clinical microbiology.

Cytomegalovirus seminal shedding in healthy volunteer sperm donors.

C. Mengelle, J. Puel, M. Segondy, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Quantitative western immunoblotting analysis in survey of human immunodeficiency virus-seropositive patients

J. Puel, D. G. Schiavini, S. Averous, 1989, Journal of clinical microbiology.

Screening of blood from potential organ and cornea donors for viruses

L. Rostaing, K. Sandres‐Saune, J. Puel, 2002, Journal of medical virology.

Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil.

L. Rostaing, J. Puel, J. Izopet, 2000, Transplantation.

Is long-term chronic immunosuppression therapy detrimental in hepatitis C virus-positive renal transplant patients?

L. Rostaing, J. Puel, J. Izopet, 1998, Transplantation proceedings.

Influence of pregnancy on human immunodeficiency virus disease.

A. Berrebi, J. Puel, G. Pontonnier, 1990, European journal of obstetrics, gynecology, and reproductive biology.

High Rate of Hepatitis C Virus Clearance in Hemodialysis Patients after Interferon-α Therapy

L. Rostaing, J. Puel, J. Izopet, 1997 .

High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy.

L. Rostaing, J. Puel, J. Izopet, 1997, The Journal of infectious diseases.

Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.

L. Rostaing, J. Puel, J. Izopet, 1995, Transplantation.

Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.

L. Rostaing, J. Puel, J. Izopet, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Experimental study of transplacental passage of alpha interferon by two assay techniques

Dumas Jc, J. Puel, J. Dumas, 1993, Antimicrobial Agents and Chemotherapy.

Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV.

A. Berrebi, P. Massip, C. Pasquier, 2003, Journal of medical virology.

Surveillance Network for Herpes Simplex Virus Resistance to Antiviral Drugs: 3-Year Follow-Up

D. Raoult, H. Fleury, C. Mengelle, 2004, Journal of Clinical Microbiology.

Brief Report: First Molecular Characterization of HIV‐1 Tunisian Strains

C. Pasquier, J. Puel, J. Izopet, 2001, Journal of acquired immune deficiency syndromes.

Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children

A. Berrebi, P. Massip, C. Pasquier, 2000, AIDS.

Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1

J. Puel, A. J. Brown, C. Wade, 1995, Journal of virology.

Diagnosis of endocarditis in acute Q-fever by immunofluorescence serology.

D. Raoult, J. Puel, J. Etienne, 1988, Acta virologica.

Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit.

C. Pasquier, L. Rostaing, J. Puel, 1999, Journal of medical virology.

Viral load and mother-to-infant HIV transmission

A. Berrebi, J. Puel, J. Izopet, 1992, The Lancet.

Assessment of a standardized reverse-transcriptase PCR assay for quantifying HIV-1 RNA in plasma and serum.

P. Massip, J. Puel, J. Izopet, 1996, Journal of virological methods.

A new generation of serum anti-HIV antibody immunocapture assay for saliva testing.

C. Pasquier, J. Puel, J. Izopet, 1997, Clinical and diagnostic virology.

Genetic Heterogeneity of Hypervariable Region 1 of the Hepatitis C Virus (HCV) Genome and Sensitivity of HCV to Alpha Interferon Therapy

C. Pasquier, J. Puel, J. Izopet, 2000, Journal of Virology.

Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha‐interferon therapy

J. Puel, J. Izopet, J. Vinel, 1998, Journal of medical virology.

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine

P. Massip, C. Pasquier, J. Puel, 1999, Journal of medical virology.

Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies

C. Pasquier, J. Puel, J. Izopet, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.

C. Katlama, J. Puel, L. Mandelbrot, 1997, The Journal of infectious diseases.

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease

B. Masquelier, H. Fleury, C. Rouzioux, 1996 .

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

C. Pasquier, L. Rostaing, J. Puel, 2000, The Journal of infectious diseases.

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection.

J. Puel, J. Izopet, J. Vinel, 1997, Gastroenterology.

Better efficacy of a 12‐month interferon alfa‐2b retreatment in patients with chronic hepatitis C relapsing after a 6‐month treatment: A multicenter, controlled, randomized trial

J. Puel, J. Izopet, J. Seigneurin, 1998, Hepatology.

Comparison of the QUANTIPLEX HIV-1 RNA 2.0 Assay with the AMPLICOR HIV-1 MONITOR 1.0 Assay for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma of Patients Receiving Stavudine-Didanosine Combination Therapy

M. Peeters, C. Pasquier, J. Puel, 1998, Journal of Clinical Microbiology.

Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

P. Massip, C. Pasquier, J. Puel, 2000, AIDS.

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.

H. Fleury, P. Massip, J. Puel, 1999, AIDS.

Determination of HCV Genotype Using Two Antibody Assays and Genome Typing

C. Pasquier, J. Puel, J. Izopet, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Cytomegalovirus detection in cryopreserved semen samples collected for therapeutic donor insemination.

C. Mengelle, J. Puel, M. Segondy, 1997, Human reproduction.

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.

B. Masquelier, C. Rouzioux, D. Dormont, 1996, JAMA.

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations

P. Massip, C. Pasquier, J. Puel, 1999, Journal of medical virology.

Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls

A. Cambon-Thomsen, M. Clanet, A. Alpérovitch, 1991, Human Immunology.

Occurrence of viruses in human stools in the Ahaggar (Algeria)

J. Puel, O. Akacem, R. Bauriaud, 1982, Journal of Hygiene.

Intermittent human immunodeficiency type 1 virus (HIV-1) shedding in semen and efficiency of sperm processing despite high seminal HIV-1 RNA levels.

M. Alvarez, P. Massip, C. Pasquier, 2002, Fertility and sterility.

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV‐1 infection

P. Massip, C. Pasquier, J. Puel, 2000, Journal of medical virology.

Risk factors in multiple sclerosis: a population‐based case‐control study in Hautes‐Pyrénées, France

J. Ruidavets, M. Clanet, A. Alpérovitch, 1989, Acta neurologica Scandinavica.

Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV‐1 resistance genotype

P. Massip, C. Pasquier, J. Puel, 2002, Journal of medical virology.

Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression.

P. Massip, C. Pasquier, J. Puel, 2002, Virology.

Quantification of HIV‐1 proviral DNA by a standardized colorimetric PCR‐based assay

P. Massip, C. Pasquier, J. Puel, 1998, Journal of medical virology.

Molecular Evidence for Mother-to-Child Transmission of Multiple Variants by Analysis of RNA and DNA Sequences of Human Immunodeficiency Virus Type 1

A. Berrebi, C. Pasquier, J. Puel, 1998, Journal of Virology.

HIV-1 subtyping using phylogenetic analysis of pol gene sequences.

C. Pasquier, J. Puel, J. Izopet, 2001, Journal of Virological Methods.

Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon‐α

C. Pasquier, J. Puel, J. Izopet, 2002, Journal of medical virology.

[Hepatitis C virus reinfection after an intravenous drug injection].

J. Puel, J. Izopet, J. Payen, 1998, Gastroenterologie clinique et biologique.

Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.

G. Salama, P. Massip, C. Pasquier, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.